Applied Viromics

Applied Viromics operates as a specialized service provider in the viral vector space, focusing on custom AAV and adenovirus production for gene delivery. Founded in 2017 and based in Bellevue, Washington, the company supports external research and development pipelines rather than developing its own therapeutic assets. Its business model is built on providing essential tools and services to accelerate early-stage discovery for partners working in infectious diseases, vaccines, and broader gene therapy fields. As a private, likely pre-revenue entity, it occupies a niche but critical position in the biotech ecosystem.

Platform for custom design, construction, and production of recombinant adeno-associated virus (AAV) and adenovirus vectors for gene delivery in research and pre-clinical applications.

Applied Viromics competes in the viral vector CRO/CDMO space, facing competition from large players like Thermo Fisher Scientific (Brammer Bio), Charles River Laboratories, and Catalent, as well as numerous smaller specialty CROs and academic core facilities. Differentiation is achieved through niche focus, customization, and personalized service for early-stage projects.